The Big Potential of Small Particles: Lipid-Based Nanoparticles and Exosomes in Vaccination

Vaccines (Basel). 2022 Jul 13;10(7):1119. doi: 10.3390/vaccines10071119.

Abstract

Some of the most significant medical achievements in recent history are the development of distinct and effective vaccines, and the improvement of the efficacy of previously existing ones, which have contributed to the eradication of many dangerous and life-threatening diseases. Immunization depends on the generation of a physiological memory response and protection against infection. It is therefore crucial that antigens are delivered in an efficient manner, to elicit a robust immune response. The recent approval of COVID-19 vaccines containing lipid nanoparticles encapsulating mRNA demonstrates the broad potential of lipid-based delivery systems. In light of this, the present review article summarizes currently synthesized lipid-based nanoparticles such as liposomes, lipid-nano particles, or cell-derived exosomes.

Keywords: adjuvant; exosomes; nanotechnology; vaccines.

Publication types

  • Review

Grants and funding

This research received no external funding.